No CrossRef data available.
Article contents
[No title]
Published online by Cambridge University Press: 02 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Correspondence
- Information
- Creative Commons
- This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Copyright
- Copyright © Royal College of Psychiatrists, 1995
References
Drummond, L. M. & Davies, M. F. (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia. British Journal of Psychiatry, 162, 38–42.Google Scholar
King, D. J. & Mills, P. J. (1993) Clozapine: the Hollywell experience with the first 24 patients. Irish Journal of Psychological Medicine, 2, 205–207.Google Scholar
Meltzer, H. Y. (1992) Some personal recommendations about using Clozaril. Clozaril Newsletter, 4, 1–3.Google Scholar
Revicki, D. A., Luce, B. R., Weschler, J. M., Brown, R. E. & Adler, M. A. (1990) Cost-effectiveness of clozapine for treatment-resistant schizophrenia patients. Hospital and Community Psychiatry, 41, 850–854.Google Scholar
You have
Access
Open access
eLetters
No eLetters have been published for this article.